Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2035
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
September 28 2017
Berlin, November 6-8th 2017: Defymed is happy to announce that we will be present at the 23rd annual...
July 21 2017
Lisbon, September 11-15th 2017: Defymed will particpate at the 53rd annual meeting of the European A...